Hydrea (Hydroxyurea) plays a vital role in the treatment of resistant chronic myeloid leukemia (CML). For patients who do not respond well to other treatments, Hydrea offers hope. It works by slowing the growth of abnormal white blood cells, which helps control the disease and reduce symptoms like fatigue, fever, and bone pain. Hydrea is taken by mouth, making it easier to use compared to some treatments. Doctors often recommend it when other options fail or cause too many side effects. With regular monitoring, Hydrea can help patients live longer, more comfortable lives. It truly is a lifeline.

Read more: https://www.specialitymedz.com/product/hydrea/